Education
About Us
Working with TipRanks
Follow Us
Aziyo Biologics (ELUT)
NASDAQ:ELUT
Aziyo Biologics (ELUT) Ownership Overview
27.94% Insiders
3.36% Mutual Funds
42.51% Other Institutional Investors
2.92% ETFs
23.27% Public Companies and
Individual Investors
The ownership structure of Aziyo Biologics (ELUT) stock is a mix of institutional, retail, and individual investors. Approximately 48.79% of the company’s stock is owned by Institutional Investors, 27.94% is owned by Insiders, and 23.27% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 13, 2025 | xxxxxxxxxxxxx | $1050000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,520,232 | Insider | 25.87% | 19,230,869 | |
| 1,023,699 | Institution | 2.78% | 2,067,872 | |
| 957,444 | Institution | 2.60% | 1,934,037 | |
| 350,417 | Insider | 0.95% | 707,842 | |
| 321,167 | Insider | 0.87% | 648,757 | |
| 212,294 | Institution | 0.58% | 428,834 | |
| 84,835 | Insider | 0.23% | 171,367 | |
| 50,357 | Institution | 0.14% | 101,721 | |
| 42,500 | Institution | 0.12% | 85,850 | |
| 23,021 | Institution | 0.06% | 46,502 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 957,444 | Institution | 2.60% | 1,934,037 | |
| 212,294 | Institution | 0.58% | 428,834 | |
| 42,500 | Institution | 0.12% | 85,850 | |
| 23,021 | Institution | 0.06% | 46,502 | |
| 2,297 | Institution | <0.01% | 4,640 | |
| 539 | Institution | <0.01% | 1,089 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 785,645 | Institution | 2.13% | 1,594,859 | |
| 238,054 | Institution | 0.65% | 483,250 | |
| 50,357 | Institution | 0.14% | 101,721 |
FAQ
Who Owns Aziyo Biologics (ELUT)?
According to the latest TipRanks data, approximately 42.51% of the company's stock is held by institutional investors, 27.94% is held by insiders, and 23.27% is held by retail investors.
What percentage of Aziyo Biologics (ELUT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 42.51% of Aziyo Biologics (ELUT) stock is held by institutional investors.
What percentage of Aziyo Biologics (ELUT) stock is held by retail investors?
According to the latest TipRanks data, approximately 23.27% of Aziyo Biologics (ELUT) stock is held by retail investors.
Who owns the most shares of Aziyo Biologics (ELUT)?
HighCape Capital, L.P. owns the most shares of Aziyo Biologics (ELUT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.